Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (111-120 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|April 23, 2004
Does the combination of alendronate and parathyroid hormone give a greater benefit than either agent alone in osteoporosis?Sheila A Doggrell
Expert Opinion on Therapeutic Targets|September 28, 2005
Stabilisation of calstabin2--a new approach in sudden cardiac deathSheila A Doggrell
Expert Opinion on Therapeutic Targets|December 9, 2004
Calstabin2 - a new target in sudden cardiac deathSheila A Doggrell
Expert Opinion on Investigational Drugs|February 16, 2005
BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemiaSheila A Doggrell
Expert Opinion on Investigational Drugs|June 4, 2004
Vascular biology support for the use of bevacizumab in colorectal cancerSheila A Doggrell
Expert Opinion on Therapeutic Targets|July 23, 2004
Is RGS-2 a new drug development target in cardiovascular disease?Sheila A Doggrell
Expert Opinion on Investigational Drugs|August 28, 2004
Dawn of Aurora kinase inhibitors as anticancer drugsSheila A Doggrell
Expert Opinion on Investigational Drugs|June 2, 2005
Berberine--a novel approach to cholesterol loweringSheila A Doggrell
Expert Opinion on Investigational Drugs|October 6, 2004
Suramin: potential in acute liver failureSheila A Doggrell
Expert Opinion on Investigational Drugs|October 6, 2004
Raising high-density lipoprotein cholesterol with inhibitors of cholesteryl ester transfer protein - a new approach to coronary artery diseaseSheila A Doggrell
Pageof 22

Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|April 23, 2004
Does the combination of alendronate and parathyroid hormone give a greater benefit than either agent alone in osteoporosis?Sheila A Doggrell
Expert Opinion on Therapeutic Targets|September 28, 2005
Stabilisation of calstabin2--a new approach in sudden cardiac deathSheila A Doggrell
Expert Opinion on Therapeutic Targets|December 9, 2004
Calstabin2 - a new target in sudden cardiac deathSheila A Doggrell
Expert Opinion on Investigational Drugs|February 16, 2005
BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemiaSheila A Doggrell
Expert Opinion on Investigational Drugs|June 4, 2004
Vascular biology support for the use of bevacizumab in colorectal cancerSheila A Doggrell
Expert Opinion on Therapeutic Targets|July 23, 2004
Is RGS-2 a new drug development target in cardiovascular disease?Sheila A Doggrell
Expert Opinion on Investigational Drugs|August 28, 2004
Dawn of Aurora kinase inhibitors as anticancer drugsSheila A Doggrell
Expert Opinion on Investigational Drugs|June 2, 2005
Berberine--a novel approach to cholesterol loweringSheila A Doggrell
Expert Opinion on Investigational Drugs|October 6, 2004
Suramin: potential in acute liver failureSheila A Doggrell
Expert Opinion on Investigational Drugs|October 6, 2004
Raising high-density lipoprotein cholesterol with inhibitors of cholesteryl ester transfer protein - a new approach to coronary artery diseaseSheila A Doggrell
Pageof 22